贾立伟, 李欣, 朱文娅, 孙涛. 牛磺熊去氧胆酸联合柳氮磺胺吡啶对小鼠结肠炎模型的药效作用及机制[J]. 解放军医学院学报, 2015, 36(11): 1134-1137,1145. DOI: 10.3969/j.issn.2095-5227.2015.11.020
引用本文: 贾立伟, 李欣, 朱文娅, 孙涛. 牛磺熊去氧胆酸联合柳氮磺胺吡啶对小鼠结肠炎模型的药效作用及机制[J]. 解放军医学院学报, 2015, 36(11): 1134-1137,1145. DOI: 10.3969/j.issn.2095-5227.2015.11.020
JIA Liwei, LI Xin, ZHU Wenya, SUN Tao. Effects and mechanisms of tauroursodeoxycholic acid combined with sulfasalazine against colitis model of mice[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2015, 36(11): 1134-1137,1145. DOI: 10.3969/j.issn.2095-5227.2015.11.020
Citation: JIA Liwei, LI Xin, ZHU Wenya, SUN Tao. Effects and mechanisms of tauroursodeoxycholic acid combined with sulfasalazine against colitis model of mice[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2015, 36(11): 1134-1137,1145. DOI: 10.3969/j.issn.2095-5227.2015.11.020

牛磺熊去氧胆酸联合柳氮磺胺吡啶对小鼠结肠炎模型的药效作用及机制

Effects and mechanisms of tauroursodeoxycholic acid combined with sulfasalazine against colitis model of mice

  • 摘要: 目的 观察牛磺熊去氧胆酸(tauroursodeoxycholic acid,TUDCA)联合柳氮磺胺吡啶(sulfasalazine,SASP)对小鼠实验性结肠炎的药效作用,初步探讨牛磺熊去氧胆酸干预结肠炎模型的可能机制。 方法 5%葡聚糖硫酸钠(dextran sulfate sodium,DSS)诱导小鼠实验性结肠炎模型。药物组给予SASP(500 mg/kg)、TUDCA(100 mg/kg)、TUDCA+SASP灌胃;正常组及模型组给予0.9%氯化钠注射液。1次/d,共8 d。观察小鼠一般状态、疾病活动指数(disease activity index,DAI)、结肠长度改变及病理组织学积分;采用免疫组化SP法检测结肠组织Hes1、Atoh1、Cdx2的表达情况,ELISA法检测血清中TNF-α、IL-6的表达量。 结果 正常组、TUDCA组、SASP组、TUDCA/SASP联合组的DAI分别为0.10±0.23、2.37±0.46、2.17±0.55、1.94±0.34,其组织学损伤评分分别为0.00±0.00、6.60±1.71、6.10±1.45、4.5±1.27,均低于模型组(3.43±0.47和9.40±1.26),差异均有统计学意义(P< 0.01);TNF-α、IL-6蛋白表达水平,正常组(46.12±8.35) ng/L、(26.89±5.45)ng/L,TUDCA组(56.48±9.02) ng/L、(27.60±4.76) ng/L,SASP组(59.15±11.09) ng/L、(26.42±5.08) ng/L,均低于模型组(70.64±7.93)ng/L、(35.12±3.51) ng/L,差异均有统计学意义(P< 0.05);正常组、TUDCA组Hes1蛋白表达分别为0.26±0.12、0.40±0.10,低于模型组(0.82±0.10),差异均有统计学意义(P< 0.01),模型组与SASP组(0.73±0.09)比较,差异无统计学意义(P> 0.05);Atoh1蛋白、Cdx2蛋白表达,正常组0.48±0.06、0.78±0.08,TUDCA组0.72±0.09、0.58±0.09,均高于模型组(0.32±0.09、0.37±0.07),差异有统计学意义(P< 0.01),模型组与SASP组Atoh1(0.30±0.10)比较,差异无统计学意义(P> 0.05)。 结论 TUDCA和SASP组均可有效减轻小鼠结肠炎模型的炎症反应,两药可能存在协同作用,联合用药效果更优。TUDCA干预机制可能与调节炎性因子,抑制Hes1蛋白激活、增加Cdx2蛋白表达有关。

     

    Abstract: Objective To observe the effects of tauroursodeoxycholic acid (TUDCA) combined with sulfasalazine (SASP) on experimental colitis of mice, and discuss the possible intervention mechanism of TUDCA to colitis model. Methods Experimental colitis model of mice were induced by drinking 5% dextran sulfate sodium (DSS). Mice in drug group were given SASP (500mg/kg), TUDCA (100mg/kg) and TUDCA combined with SASP by gastric gavage. The normal group and model group were administered with correspondingly 0.9 % saline, once per day for 8 days. The general status in mice, disease activity index (DAI), colonic length changes and the score of pathological histology were observed and Hes1, Atoh1 and Cdx2 expression in colons were assessed by immunohistochemistry (SP method). TNF-a and IL-6 expression in serum were assessed by ELISA. Results The DAI of normal group, TUDCA group, SASP group and TUDCA/SASP combined group was (0.10±0.23), (2.37±0.46), (2.17±0.55) and(1.94±0.34), respectively, the score of injury was (0.00±0.00), (6.60±1.71), (6.10±1.45) and (4.5±1.27), respectively, all were lower than those of model group (3.43±0.47), (9.40±1.26) and the differences were statistically significant (P< 0.01). The expression of TNF-a and IL-6 in protein level of normal group was (46.12±8.35) ng/L, (26.89±5.45) ng/L, (56.48±9.02) ng/L, (27.60±4.76) ng/L in TUDCA group, (59.15±11.09) ng/L, (26.42±5.08) ng/L in SASP group, respectively, all were lower than those of model group (70.64±7.93) ng/L, (35.12±3.51) ng/L and the differences were statistically significant (P< 0.05). The expression of Hes1 protein in normal group and TUDCA group was (0.26±0.12) and (0.40±0.10), respectively, which were lower than that of model group (0.82±0.10) with statistically significant differences (P< 0.01). No statistically significant difference was found between model group and SASP group (0.82±0.10) vs (0.73±0.09), P> 0.05. The expression of Atoh1 and Cdx2 at protein level of normal group was (0.48±0.06) and (0.78±0.08), (0.72±0.09) and (0.58±0.09) in TUDCA group, which were lower than those of model group (0.32±0.09), (0.37±0.07) with statistically significant differences (P< 0.01). But, no statistically significant difference was found between model group and SASP group in Atoh1 (0.32±0.09) vs (0.30±0.10), P> 0.05. Conclusion The inflammatory response of the colitis model of mice in both TUDCA and SASP group can be relieved effectively, the combination of them can do better due to the possible synergistic effect. The intervention mechanism of TUDCA may be related to the regulation of inflammatory factors, inhibition of the activity of Hes1 protein and the increase of Cdx2 protein expression.

     

/

返回文章
返回